Powerful mutators lurking in the genome

Philosophical Transactions of the Royal Society B: Biological Sciences

Volumn 364, Issue 1517, 2009, Pages 705-715

  Petit, Vincent ^a   Vartanian, Jean Pierre ^a   Wain Hobson, Simon ^a  

^a INSTITUT PASTEUR   (France)

Author keywords

Activation induced deaminase; APOBEC3; Cancer; Cytidine deaminase; Hypermutation

Indexed keywords

CANCER; ENZYME ACTIVITY; GENOME; MUTATION;

EID: 60049100687     PISSN: 09628436     EISSN: 14712970     Source Type: Journal    
DOI: 10.1098/rstb.2008.0272     Document Type: Conference Paper

References (102)

1. Abudu, A., Takaori-Kondo, A., Izumi, T., Shirakawa, K., Kobayashi, M., Sasada, A., Fukunaga, K. & Uchiyama, T. 2006 Murine retrovirus escapes from murine APOBEC3 via two distinct novel mechanisms. Curr. Biol. 16, 1565-1570. (doi:10.1016/j.cub.2006.06.055)
2. Andersen, P. R., Barbacid, M., Tronick, S. R., Clark, H. F. & Aaronson, S. A. 1979 Evolutionary relatedness of viper and primate endogenous retroviruses. Science 204, 318-321. (doi:10.1126/science.219480)
3. Arbyn, M. & Dillner, J. 2007 Review of current knowledge on HPV vaccination: an appendix to the European Guidelines for Quality Assurance in Cervical Cancer Screening. J. Clin. Virol. 38, 189-197. (doi:10.1016/j.jcv.2006.12.009)
4. Armitage, A. E. et al. 2008 Conserved footprints of APOBEC3G on hypermutated human immunodeficiency virus type 1 and human endogenous retrovirus HERV-K(HML2) sequences. J. Virol. 82, 8743-8761. (doi:10.1128/JVI.00584-08)
5. Athanasiadis, A., Rich, A. & Maas, S. 2004 Widespread A-to-I RNA editing of Alu-containing mRNAs in the human transcriptome. PLoS Biol. 2, e391. (doi:10.1371/journal.pbio.0020391)
6. Beale, R. C., Petersen-Mahrt, S. K., Watt, I. N., Harris, R. S., Rada, C. & Neuberger, M. S. 2004 Comparison of the differential context-dependence of DNA deamination by APOBEC enzymes: correlation with mutation spectra in vivo. J. Mol. Biol. 337, 585-596. (doi:10.1016/j.jmb.2004.01.046)
7. Benveniste, R. E. & Todaro, G. J. 1974 Evolution of type C viral genes: I. Nucleic acid from baboon type C virus as a measure of divergence among primate species. Proc. Natl Acad. Sci. USA 71, 4513-4518. (doi:10.1073/pnas.71.11.4513)
8. Biebricher, C. K. & Eigen, M. 2006 What is a quasispecies? Curr. Top. Microbiol. Immunol. 299, 1-31. (doi:10.1007/3-540-26397-7-1)
9. Blow, M., Futreal, P. A., Wooster, R. & Stratton, M. R. 2004 A survey of RNA editing in human brain. Genome Res. 14, 2379-2387. (doi:10.1101/gr.2951204)
10. Bogerd, H. P., Wiegand, H. L., Hulme, A. E., Garcia-Perez, J. L., O'Shea, K. S., Moran, J. V. & Cullen, B. R. 2006 Cellular inhibitors of long interspersed element 1 and Alu retrotransposition. Proc. Natl Acad. Sci. USA 103, 8780-8785. (doi:10.1073/pnas.0603313103)
11. Bogerd, H. P., Tallmadge, R. L., Oaks, J. L., Carpenter, S. & Cullen, B. R. In press. Equine infectious anemia virus resists the anti-retroviral activity of equine APOBEC3 proteins through a packaging-independent mechanism. J. Virol.
12. Bonvin, M. et al. 2006 Interferon-inducible expression of APOBEC3 editing enzymes in human hepatocytes and inhibition of hepatitis B virus replication. Hepatology 43, 1364-1374. (doi:10.1002/hep.21187)
13. Chen, S. H. et al. 1987 Apolipoprotein B-48 is the product of a messenger RNA with an organ-specific in-frame stop codon. Science 238, 363-366. (doi:10.1126/science.3659919)
14. Cogliano, V., Baan, R., Straif, K., Grosse, Y., Secretan, B., El Ghissassi, F. & WHO International Agency for Research on Cancer 2005 Carcinogenicity of human papillomaviruses. Lancet Oncol. 6, 204.
15. Dang, Y., Wang, X., Esselman, W. J. & Zheng, Y. H. 2006 Identification of APOBEC3DE as another antiretroviral factor from the human APOBEC family. J. Virol. 80, 10522-10533. (doi:10.1128/JVI.01123- 06)
16. Delebecque, F., Suspène, R., Calattini, S., Casartelli, N., Saib, A., Froment, A., Wain-Hobson, S., Gessain, A., Vartanian, J. P. & Schwartz, O. 2006 Restriction of foamy viruses by APOBEC cytidine deaminases. J. Virol. 80, 605-614. (doi:10.1128/JVI.80.2.605-614.2006)
17. Desrosiers, R. C., Lifson, J. D., Gibbs, J. S., Czajak, S. C., Howe, A. Y., Arthur, L. O. & Johnson, R. P. 1998 Identification of highly attenuated mutants of simian immunodeficiency virus. J. Virol. 72, 1431-1437.
18. de Villiers, E. M., Fauquet, C., Broker, T. R., Bernard, H. U. & zur Hausen, H. 2004 Classification of papillomaviruses. Virology 324, 17-27. (doi:10.1016/j.virol.2004.03.033)
19. Doehle, B. P., Schafer, A., Wiegand, H. L., Bogerd, H. P. & Cullen, B. R. 2005 Differential sensitivity of murine leukemia virus to APOBEC3-mediated inhibition is governed by virion exclusion. J. Virol. 79, 8201-8207. (doi:10.1128/JVI.79.13.8201-8207.2005)
20. Drake, J. W. 1993 Rates of spontaneous mutation among RNA viruses. Proc. Natl Acad. Sci. USA 90, 4171-4175. (doi:10.1073/pnas.90.9. 4171)
21. Eisenberg, E., Nemzer, S., Kinar, Y., Sorek, R., Rechavi, G. & Levanon, E. Y. 2005 Is abundant A-to-I RNA editing primate-specific? Trends Genet. 21, 77-81. (doi:10.1016/j.tig.2004.12.005)
22. Esnault, C., Heidmann, O., Delebecque, F., Dewannieux, M., Ribet, D., Hance, A. J., Heidmann, T. & Schwartz, O. 2005 APOBEC3G cytidine deaminase inhibits retrotransposition of endogenous retroviruses. Nature 433, 430-433. (doi:10.1038/nature03238)
23. Gallois-Montbrun, S., Kramer, B., Swanson, C. M., Byers, H., Lynham, S., Ward, M. & Malim, M. H. 2007 Antiviral protein APOBEC3G localizes to ribonucleoprotein complexes found in P bodies and stress granules. J. Virol. 81, 2165-2178. (doi:10.1128/JVI.02287-06)
24. Gallois-Montbrun, S., Holmes, R. K., Swanson, C. M., Fernandez-Ocana, M., Byers, H. L., Ward, M. A. & Malim, M. H. 2008 Comparison of cellular ribonucleoprotein complexes associated with the APOBEC3F and APOBEC3G antiviral proteins. J. Virol. 82, 5636-5642. (doi:10.1128/JVI.00287-08)
25. Gojobori, T., Li, W. H. & Graur, D. 1982 Patterns of nucleotide substitution in pseudogenes and functional genes. J. Mol. Evol. 18, 360-369. (doi:10.1007/BF01733904)
26. Gommers-Ampt, J. H. & Borst, P. 1995 Hypermodified bases in DNA. FASEB J. 9, 1034-1042.
27. Greenman, C. et al. 2007 Patterns of somatic mutation in human cancer genomes. Nature 446, 153-158. (doi:10.1038/nature05610)
28. Günther, S., Sommer, G., Plikat, U., Iwanska, A., Wain-Hobson, S., Will, H. & Meyerhans, A. 1997 Naturally occurring hepatitis B virus genomes bearing the hallmarks of retroviral G→A hypermutation. Virology 235, 104-108. (doi:10.1006/viro.1997.8676)
29. Harris, R. S., Petersen-Mahrt, S. K. & Neuberger, M. S. 2002 RNA editing enzyme APOBEC1 and some of its homologs can act as DNA mutators. Mol. Cell 10, 1247-1253. (doi:10.1016/S1097-2765(02)00742-6)
30. Harris, R. S., Bishop, K. N., Sheehy, A. M., Craig, H. M., Petersen-Mahrt, S. K., Watt, I. N., Neuberger, M. S. & Malim, M. H. 2003 DNA deamination mediates innate immunity to retroviral infection. Cell 113, 803-809. (doi:10.1016/S0092-8674(03)00423-9)
31. Holland, J. J., Domingo, E., de la Torre, J. C. & Steinhauer, D. A. 1990 Mutation frequencies at defined single codon sites in vesicular stomatitis virus and poliovirus can be increased only slightly by chemical mutagenesis. J. Virol. 64, 3960-3962.
32. Huder, J. B., Boni, J., Hatt, J. M., Soldati, G., Lutz, H. & Schupbach, J. 2002 Identification and characterization of two closely related unclassifiable endogenous retroviruses in pythons (Python molurus and Python curtus). J. Virol. 76, 7607-7615. (doi:10.1128/JVI.76.15.7607-7615.2002)
33. Innerarity, T. L., Boren, J., Yamanaka, S. & Olofsson, S. O. 1996 Biosynthesis of apolipoprotein B48-containing lipoproteins. Regulation by novel post-transcriptional mechanisms. J. Biol. Chem. 271, 2353-2356. (doi:10.1074/jbc.271.5.2353)
34. Jarmuz, A., Chester, A., Bayliss, J., Gisbourne, J., Dunham, I., Scott, J. & Navaratnam, N. 2002 An anthropoid-specific locus of orphan C to U RNA-editing enzymes on chromosome 22. Genomics 79, 285-296. (doi:10.1006/geno.2002.6718)
35. Jern, P., Stoye, J. P. & Coffin, J. M. 2007 Role of APOBEC3 in genetic diversity among endogenous murine leukemia viruses. PLoS Genet. 3, 2014-2022. (doi:10.1371/journal.pgen.0030183)
36. Jonsson, S. R., LaRue, R. S., Stenglein, M. D., Fahrenkrug, S. C., Andresdottir, V. & Harris, R. S. 2007 The restriction of zoonotic PERV transmission by human APOBEC3G. PLoS ONE 2, e893. (doi:10.1371/journal.pone.0000893)
37. Katzourakis, A., Tristem, M., Pybus, O. G. & Gifford, R. J. 2007 Discovery and analysis of the first endogenous lentivirus. Proc. Natl Acad. Sci. USA 104, 6261-6265. (doi:10.1073/pnas.0700471104)
38. Kieffer, T. L., Kwon, P., Nettles, R. E., Han, Y., Ray, S. C. & Siliciano, R. F. 2005 G→A hypermutation in protease and reverse transcriptase regions of human immunodeficiency virus type 1 residing in resting CD4C+T cells in vivo. J. Virol. 79, 1975-1980. (doi:10.1128/JVI.79.3.1975-1980.2005)
39. Kijak, G. H., Janini, L. M., Tovanabutra, S., Sanders-Buell, E., Arroyo, M. A., Robb, M. L., Michael, N. L., Birx, D. L. & McCutchan, F. E. 2008 Variable contexts and levels of hypermutation in HIV-1 proviral genomes recovered from primary peripheral blood mononuclear cells. Virology 376, 101-111. (doi:10.1016/j.virol.2008.03.017)
40. Kim, D. D., Kim, T. T., Walsh, T., Kobayashi, Y., Matise, T. C., Buyske, S. & Gabriel, A. 2004 Widespread RNA editing of embedded alu elements in the human transcriptome. Genome Res. 14, 1719-1725. (doi:10.1101/gr.2855504)
41. Kinomoto, M., Kanno, T., Shimura, M., Ishizaka, Y., Kojima, A., Kurata, T., Sata, T. & Tokunaga, K. 2007 All APOBEC3 family proteins differentially inhibit LINE-1 retrotransposition. Nucleic Acids Res. 35, 2955-2964. (doi:10.1093/nar/gkm181)
42. Kirnos, M. D., Khudyakov, I. Y., Alexandrushkina, N. I. & Vanyushin, B. F. 1977 2-Aminoadenine is an adenine substituting for a base in S-2L cyanophage DNA. Nature 270, 369-370. (doi:10.1038/270369a0)
43. Komori, J. et al. 2008 Activation-induced cytidine deaminase links bile duct inflammation to human cholangiocarcinoma. Hepatology 47, 888-896. (doi:10.1002/hep.22125)
44. Kou, T. et al. 2007 Expression of activation-induced cytidine deaminase in human hepatocytes during hepatocarcinogenesis. Int. J. Cancer 120, 469-476. (doi:10.1002/ijc.22292)
45. Krawczak, M., Smith-Sorensen, B., Schmidtke, J., Kakkar, V. V., Cooper, D. N. & Hovig, E. 1995 Somatic spectrum of cancer-associated single basepair substitutions in the TP53 gene is determined mainly by endogenous mechanisms of mutation and by selection. Hum. Mutat. 5, 48-57. (doi:10.1002/humu.1380050107)
46. Lecossier, D., Bouchonnet, F., Clavel, F. & Hance, A. J. 2003 Hypermutation of HIV-1 DNA in the absence of the Vif protein. Science 300, 1112. (doi:10.1126/science.1083338)
47. Lee, Y. N., Malim, M. H. & Bieniasz, P. D. 2008 Hypermutation of an ancient human retrovirus by APOBEC3G. J. Virol. 82, 8762-8770. (doi:10.1128/JVI.00751-08)
48. Levanon, E. Y. et al. 2004 Systematic identification of abundant A-to-I editing sites in the human transcriptome. Nat. Biotechnol. 22, 1001-1005. (doi:10.1038/nbt996)
49. Levanon, E. Y., Hallegger, M., Kinar, Y., Shemesh, R., Djinovic-Carugo, K., Rechavi, G., Jantsch, M. F. & Eisenberg, E. 2005 Evolutionarily conserved human targets of adenosine to inosine RNA editing. Nucleic Acids Res. 33, 1162-1168. (doi:10.1093/nar/gki239)
50. Liddament, M. T., Brown, W. L., Schumacher, A. J. & Harris, R. S. 2004 APOBEC3F properties and hypermutation preferences indicate activity against HIV-1 in vivo. Curr. Biol. 14, 1385-1391. (doi:10.1016/j.cub. 2004.06.050)
51. Maas, S., Gerber, A. P. & Rich, A. 1999 Identification and characterization of a human tRNA-specific adenosine deaminase related to the ADAR family of pre-mRNA editing enzymes. Proc. Natl Acad. Sci. USA 96, 8895-8900. (doi:10.1073/pnas.96.16.8895)
52. Madsen, P. et al. 1999 Psoriasis upregulated phorbolin-1 shares structural but not functional similarity to the mRNA-editing protein APOBEC-1. J. Invest. Dermatol. 113, 162-169. (doi:10.1046/j.1523-1747.1999. 00682.x)
53. Mahieux, R., Suspène, R., Delebecque, F., Henry, M., Schwartz, O., Wain-Hobson, S. & Vartanian, J. P. 2005 Extensive editing of a small fraction of human T-cell leukemia virus type 1 genomes by four APOBEC3 cytidine deaminases. J. Gen. Virol. 86, 2489-2494. (doi:10.1099/vir.0. 80973-0)
54. Mangeat, B., Turelli, P., Caron, G., Friedli, M., Perrin, L. & Trono, D. 2003 Broad antiretroviral defence by human APOBEC3G through lethal editing of nascent reverse transcripts. Nature 424, 99-103. (doi:10.1038/nature01709)
55. Mariani, R., Chen, D., Schrofelbauer, B., Navarro, F., Konig, R., Bollman, B., Munk, C., Nymark-McMahon, H. & Landau, N. R. 2003 Species-specific exclusion of APOBEC3G from HIV-1 virions by Vif. Cell 114, 21-31. (doi:10.1016/S0092-8674(03)00515-4)
56. Marusawa, H. 2008 Aberrant AID expression and human cancer development. Int. J. Biochem. Cell. Biol. 40, 1399-1402. (doi:10.1016/j.biocel. 2008.01.018)
57. Matsumoto, Y. et al. 2007 Helicobacter pylori infection triggers aberrant expression of activation-induced cytidine deaminase in gastric epithelium. Nat. Med. 13, 470-476. (doi:10.1038/nm1566)
58. Maynard Smith, J. 1970 Natural selection and the concept of a protein space. Nature 225, 563-564. (doi:10.1038/225563a0)
59. Meyerhans, A., Cheynier, R., Albert, J., Seth, M., Kwok, S., Sninsky, J., Morfeldt-Manson, L., Asjo, B. & Wain-Hobson, S. 1989 Temporal fluctuations in HIV quasispecies in vivo are not reflected by sequential HIV isolations. Cell 58, 901-910. (doi:10.1016/0092-8674(89)90942-2)
60. Mikl, M. C., Watt, I. N., Lu, M., Reik, W., Davies, S. L., Neuberger, M. S. & Rada, C. 2005 Mice deficient in APOBEC2 and APOBEC3. Mol. Cell Biol. 16, 7270-7277. (doi:10.1128/MCB.25.16.7270-7277.2005)
61. Morisawa, T., Marusawa, H., Ueda, Y., Iwai, A., Okazaki, I. M., Honjo, T. & Chiba, T. 2008 Organ-specific profiles of genetic changes in cancers caused by activation-induced cytidine deaminase expression. Int. J. Cancer 123, 2735-2740. (doi:10.1002/ijc.23853)
62. Muckenfuss, H., Hamdorf, M., Held, U., Perkovic, M., Lower, J., Cichutek, K., Flory, E., Schumann, G. G. & Munk, C. 2006 APOBEC3 proteins inhibit human LINE-1 retrotransposition. J. Biol. Chem. 281, 22161-22172. (doi:10.1074/jbc.M601716200)
63. Muramatsu, M., Sankaranand, V. S., Anant, S., Sugai, M., Kinoshita, K., Davidson, N. O. & Honjo, T. 1999 Specific expression of activation-induced cytidine deaminase (AID), a novel member of the RNA-editing deaminase family in germinal center B cells. J. Biol. Chem. 274, 18470-18476. (doi:10.1074/jbc.274.26.18470)
64. Muramatsu, M., Kinoshita, K., Fagarasan, S., Yamada, S., Shinkai, Y. & Honjo, T. 2000 Class switch recombination and hypermutation require activation-induced cytidine deaminase (AID), a potential RNA editing enzyme. Cell 102, 553-563. (doi:10.1016/S0092-8674(00)00078-7)
65. Noguchi, C., Ishino, H., Tsuge, M., Fujimoto, Y., Imamura, M., Takahashi, S. & Chayama, K. 2005 G to A hypermutation of hepatitis B virus. Hepatology 41, 626-633. (doi:10.1002/hep.20580)
66. OhAinle, M., Kerns, J. A., Malik, H. S. & Emerman, M. 2006 Adaptive evolution and antiviral activity of the conserved mammalian cytidine deaminase APOBEC3H. J. Virol. 80, 3853-3862. (doi:10.1128/JVI.80.8.3853- 3862.2006)
67. OhAinle, M., Kerns, J. A., Li, M. M., Malik, H. S. & Emerman, M. 2008 Antiretroelement activity of APOBEC3H was lost twice in recent human evolution. Cell Host Microbe 4, 249-259. (doi:10.1016/j.chom.2008.07.005)
68. Okeoma, C. M., Lovsin, N., Peterlin, B. M. & Ross, S. R. 2007 APOBEC3 inhibits mouse mammary tumour virus replication in vivo. Nature 445, 927-930. (doi:10.1038/nature05540)
69. Paul, T. A., Quackenbush, S. L., Sutton, C., Casey, R. N., Bowser, P. R. & Casey, J. W. 2006 Identification and characterization of an exogenous retrovirus from atlantic salmon swim bladder sarcomas. J. Virol. 80, 2941-2948. (doi:10.1128/JVI.80.6.2941-2948.2006)
70. Peng, G., Lei, K. J., Jin, W., Greenwell-Wild, T. & Wahl, S. M. 2006 Induction of APOBEC3 family proteins, a defensive maneuver underlying interferon-induced anti-HIV-1 activity. J. Exp. Med. 203, 41-46. (doi:10.1084/jem.20051512)
71. Petersen-Mahrt, S. K. & Neuberger, M. S. 2003 In vitro deamination of cytosine to uracil in single-stranded DNA by apolipoprotein B editing complex catalytic subunit 1 (APOBEC1). J. Biol. Chem. 278, 19 583-19 586. (doi:10.1074/jbc.C300114200)
72. Petit, V., Guétard, D., Renard, M., Keriel, A., Sitbon, M., Wain-Hobson, S. & Vartanian, J. P. 2009 Murine APOBEC1 is a powerful mutator of retroviral and cellular RNA in vitro and in vivo. J. Mol. Biol. 385, 65-78. (doi:10.1016/j.jmb.2008.10.043)
73. Powell, L. M., Wallis, S. C., Pease, R. J., Edwards, Y. H., Knott, T. J. & Scott, J. 1987 A novel form of tissue-specific RNA processing produces apolipoprotein-B48 in intestine. Cell 50, 831-840. (doi:10.1016/0092-8674(87)90510-1)
74. Prochnow, C., Bransteitter, R., Klein, M. G., Goodman, M. F. & Chen, X. S. 2007 The APOBEC-2 crystal structure and functional implications for the deaminase AID. Nature 445, 447-451. (doi:10.1038/nature05492)
75. Rogozin, I. B., Basu, M. K., Jordan, I. K., Pavlov, Y. I. & Koonin, E. V. 2005 APOBEC4, a new member of the AID/APOBEC family of polynucleotide (deoxy)cytidine deaminases predicted by computational analysis. Cell Cycle 4, 1281-1285.
76. Rulli Jr, S. J., Mirro, J., Hill, S. A., Lloyd, P., Gorelick, R. J., Coffin, J. M., Derse, D. & Rein, A. 2008 Interactions of murine APOBEC3 and human APOBEC3G with murine leukemia viruses. J. Virol. 82, 6566-6575. (doi:10.1128/JVI.01357-07)
77. Samuel, C. E. 2001 Antiviral actions of interferons. Clin. Microbiol. Rev. 14, 778-809. (doi:10.1128/CMR.14.4.778-809.2001)
78. Santiago, M. L., Montano, M., Benitez, R., Messer, R. J., Yonemoto, W., Chesebro, B., Hasenkrug, K. J. & Greene, W. C. 2008 APOBEC3 encodes Rfv3, a gene influencing neutralizing antibody control of retrovirus infection. Science 321, 1343-1346. (doi:10.1126/science.1161121)
79. Scadden, A. D. 2005 The RISC subunit Tudor-SN binds to hyper-edited double-stranded RNA and promotes its cleavage. Nat. Struct. Mol. Biol. 12, 489-496. (doi:10.1038/nsmb936)
80. Schmid, A., Spielhofer, P., Cattaneo, R., Baczko, K., ter Meulen, V. & Billeter, M. A. 1992 Subacute sclerosing panencephalitis is typically characterized by alterations in the fusion protein cytoplasmic domain of the persisting measles virus. Virology 188, 910-915. (doi:10.1016/0042-6822(92)90552-Z)
81. Schumacher, A. J., Nissley, D. V. & Harris, R. S. 2005 APOBEC3G hypermutates genomic DNA and inhibits Ty1 retrotransposition in yeast. Proc. Natl Acad. Sci. USA 102, 9854-9859. (doi:10.1073/pnas.0501694102)
82. Schumacher, A. J., Hache, G., Macduff, D. A., Brown, W. L. & Harris, R. S. 2008 The DNA deaminase activity of human APOBEC3G is required for Ty1, MusD, and human immunodeficiency virus type 1 restriction. J. Virol. 82, 2652-2660. (doi:10.1128/JVI.02391-07)
83. Sheehy, A. M., Gaddis, N. C., Choi, J. D. & Malim, M. H. 2002 Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein. Nature 418, 646-650. (doi:10.1038/nature00939)
84. Shen, C. H. & Steiner, L. A. 2004 Genome structure and thymic expression of an endogenous retrovirus in zebrafish. J. Virol. 78, 899-911. (doi:10.1128/JVI.78.2.899-911.2004)
85. Suspène, R. et al. 2004 APOBEC3G is a single-stranded DNA cytidine deaminase and functions independently of HIV reverse transcriptase. Nucleic Acids Res. 32, 2421-2429. (doi:10.1093/nar/gkh554)
86. Suspène, R., Guétard, D., Henry, M., Sommer, P., Wain-Hobson, S. & Vartanian, J. P. 2005a Extensive editing of both hepatitis B virus DNA strands by APOBEC3 cytidine deaminases in vitro and in vivo. Proc. Natl Acad. Sci. USA 102, 8321-8326. (doi:10.1073/pnas.0408223102)
87. Suspène, R., Henry, M., Guillot, S., Wain-Hobson, S. & Vartanian, J. P. 2005b Recovery of APOBEC3-edited human immunodeficiency virus G→A hypermutants by differential DNA denaturation PCR. J. Gen. Virol. 86, 125-129. (doi:10.1099/vir.0.80426-0)
88. Suspène, R., Rusniok, C., Vartanian, J. P. & Wain-Hobson, S. 2006 Twin gradients in APOBEC3 edited HIV-1 DNA reflect the dynamics of lentiviral replication. Nucleic Acids Res. 34, 4677-4684. (doi:10.1093/nar/gkl555)
89. Suspène, R. et al. 2008 Inversing the natural hydrogen bonding rule to selectively amplify GC-rich ADAR-edited RNAs. Nucleic Acids Res. 36, e72. (doi:10.1093/nar/gkn295)
90. Takeda, E., Tsuji-Kawahara, S., Sakamoto, M., Langlois, M. A., Neuberger, M. S., Rada, C. & Miyazawa, M. 2008 Mouse APOBEC3 restricts Friend leukemia virus infection and pathogenesis in vivo. J. Virol. 82, 10998. (doi:10.1128/JVI.01311-08)
91. Tanaka, Y. et al. 2006 Anti-viral protein APOBEC3G is induced by interferon-alpha stimulation in human hepatocytes. Biochem. Biophys. Res. Commun. 341, 314-319. (doi:10.1016/j.bbrc.2005.12.192)
92. Trivedi, N. R., Gilliland, K. L., Zhao, W., Liu, W. & Thiboutot, D. M. 2006 Gene array expression profiling in acne lesions reveals marked upregulation of genes involved in inflammation and matrix remodeling. J. Invest. Dermatol. 126, 1071-1079. (doi:10.1038/sj.jid.5700213)
93. Valente, L. & Nishikura, K. 2005 ADAR gene family and Ato-I RNA editing: diverse roles in posttranscriptional gene regulation. Prog. Nucleic Acid Res. Mol. Biol. 79, 299-338.
94. Vartanian, J. P., Plikat, U., Henry, M., Mahieux, R., Guillemot, L., Meyerhans, A. & Wain-Hobson, S. 1997 HIV genetic variation is directed and restricted by DNA precursor availability. J. Mol. Biol. 270, 139-151. (doi:10.1006/jmbi.1997.1104)
95. Vartanian, J. P., Henry, M. & Wain-Hobson, S. 2002 Sustained G→A hypermutation during reverse transcription of an entire human immunodeficiency virus type 1 strain Vau group O genome. J. Gen. Virol. 83, 801-805.
96. Vartanian, J. P., Guétard, D., Henry, M. & Wain-Hobson, S. 2008 Evidence for editing of human papillomavirus DNA by APOBEC3 in benign and precancerous lesions. Science 320, 230-233. (doi:10.1126/science. 1153201)
97. Wain-Hobson, S. 2006 The third bond. Nature 439, 539. (doi:10.1038/439539a)
98. Wiegand, H. L., Doehle, B. P., Bogerd, H. P. & Cullen, B. R. 2004 A second human antiretroviral factor, APOBEC3F, is suppressed by the HIV-1 and HIV-2 Vif proteins. EMBO J. 23, 2451-2458. (doi:10.1038/sj.emboj. 7600246)
99. Yamanaka, S., Balestra, M. E., Ferrell, L. D., Fan, J., Arnold, K. S., Taylor, S., Taylor, J. M. & Innerarity, T. L. 1995 Apolipoprotein B mRNA-editing protein induces hepatocellular carcinoma and dysplasia in transgenic animals. Proc. Natl Acad. Sci. USA 92, 8483-8487. (doi:10.1073/pnas.92.18.8483)
100. Yu, Q., Konig, R., Pillai, S., Chiles, K., Kearney, M., Palmer, S., Richman, D., Coffin, J. M. & Landau, N. R. 2004 Single-strand specificity of APOBEC3G accounts for minus-strand deamination of the HIV genome. Nat. Struct. Mol. Biol. 11, 435-442. (doi:10.1038/nsmb758)
101. Zhang, H., Yang, B., Pomerantz, R. J., Zhang, C., Arunachalam, S. C. & Gao, L. 2003 The cytidine deaminase CEM15 induces hypermutation in newly synthesized HIV-1 DNA. Nature 424, 94-98. (doi:10.1038/ nature01707)
102. Zheng, Y. H., Irwin, D., Kurosu, T., Tokunaga, K., Sata, T. & Peterlin, B. M. 2004 Human APOBEC3F is another host factor that blocks human immunodeficiency virus type 1 replication. J. Virol. 78, 6073-6076. (doi:10.1128/JVI.78.11.6073-6076.2004)